Friday - June 26, 2026

Category Archives: Science

Pulmonary Fibrosis Pipeline Shows Potential with Active Contributions from 110+ Key Companies | DelveInsight

DelveInsight’s, “Pulmonary Fibrosis Pipeline Insight 2026” report provides comprehensive insights about 110+ companies and 140+ pipeline drugs in Pulmonary Fibrosis pipeline landscape. It covers the Pulmonary Fibrosis Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Systemic Sclerosis Pipeline Shows Potential with Active Contributions from 50+ Key Companies | DelveInsight

DelveInsight’s, “Systemic Sclerosis Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Systemic Sclerosis pipeline landscape. It covers the Systemic Sclerosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Tenosynovial Giant Cell Tumors Pipeline Shows Potential with Active Contributions from 5+ Key Companies | DelveInsight

DelveInsight’s, “Tenosynovial Giant Cell Tumors Pipeline Insight 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Tenosynovial Giant Cell Tumors pipeline landscape. It covers the Tenosynovial Giant Cell Tumors pipeline drug profiles, including clinical and nonclinical … Continue reading →

Zika Virus Infection Pipeline Shows Potential with Active Contributions from 12+ Key Companies | DelveInsight

DelveInsight’s “Zika Virus Infection Pipeline Insight 2026” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in the Zika Virus Infection pipeline landscape. It covers the Zika Virus Infection Pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Mitochondrial Myopathies Market Forecast Through 2034: Emerging Disease-Modifying Therapies, Expanding Genetic Diagnostics, and Advancing Pipeline Innovations to Drive Significant Market Growth

DelveInsight’s Mitochondrial Myopathies Market Report Highlights Strong Growth Opportunities Across the 7MM The Mitochondrial Myopathies market is poised for remarkable growth over the forecast period, driven by advances in genetic diagnostics, increasing awareness of rare mitochondrial disorders, expanding clinical development … Continue reading →

Metastatic Castration-Resistant Prostate Cancer Market is Projected to Witness Significant Growth by 2036 Owing to the Launch of Novel Radioligand Therapies and Targeted Treatments | DelveInsight

The market dynamics for Metastatic Castration-Resistant Prostate Cancer (mCRPC) are witnessing significant growth driven by the rising prevalence of prostate cancer, increasing adoption of precision medicine and molecular diagnostics, growing utilization of radioligand therapies, and a strong late-stage pipeline of … Continue reading →

Idiopathic Pulmonary Fibrosis Market is Expected to Surpass USD 7 Billion by 2036, Driven by Rising Disease Burden and Emerging Disease-Modifying Therapies | DelveInsight

The Idiopathic Pulmonary Fibrosis Market is witnessing substantial growth driven by increasing disease prevalence, improving diagnostic capabilities, growing awareness among healthcare professionals, and expanding adoption of antifibrotic therapies. The anticipated launch of emerging therapies such as Deupirfenidone, Admilparant, NIKTIMVO, and … Continue reading →

BCL-2 Inhibitors Market is Projected to Reach USD 16 Billion by 2036, Driven by Expanding Hematologic Oncology Applications and Next-Generation Apoptosis-Targeting Therapies | DelveInsight

The BCL-2 Inhibitors Market is witnessing substantial growth driven by increasing incidence of hematologic malignancies, growing adoption of targeted therapies, rising awareness of apoptosis-based cancer treatment strategies, and a robust pipeline of next-generation BCL-2 inhibitors. The anticipated launch of emerging … Continue reading →

Vaccines Market to Reach $67.91 Billion by 2030, Driven by Expanding Immunization Programs and Advancements in Vaccine Technologies

Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, RSV), Route of Administration (IM, SC, Oral)-Global Forecast to 2030 According to MarketsandMarkets™, The global vaccines market (excluding COVID-19) is … Continue reading →